Basic Information
RNALocate ID: | RLID:11002464 |
RNA Symbol: | hsa-miR-376c-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-368 |
RNA ID: | miRBase:MIMAT0000720 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 18589210 |
Tissue/Cell Line: | Serum |
Method: | Microarray |
Description: | Association of microRNA with peripheral blood-derived tumor exosomes compared with microRNA isolated from their corresponding tumors. Data are collected from Table 1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002028 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:11002465 | Exosome | Brain tissue | 23382797 |
RLID:11002466 | Exosome | Plasma | 23663360 |
RLID:11002467 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000410 | Microvesicle | Fibroblasts|Mesenchymal stem cells|Urine | |
RLID-D:11001198 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-376c-3p | Splenic marginal zone lymphoma | MNDR-E-MI-46176 |
MNDR | hsa-miR-376c-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-46177 |
MNDR | hsa-miR-376c-3p | Oral squamous cell carcinoma | MNDR-E-MI-46178 |
MNDR | hsa-miR-376c-3p | Medulloblastoma | MNDR-E-MI-46179 |
MNDR | hsa-miR-376c-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-46180 |
MNDR | hsa-miR-376c-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-46181 |
MNDR | hsa-miR-376c-3p | Lymphoma | MNDR-E-MI-46182 |
MNDR | hsa-miR-376c-3p | Lymphoma non-hodgkin | MNDR-E-MI-46183 |
MNDR | hsa-miR-376c-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-46184 |
MNDR | hsa-miR-376c-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-46185 |
MNDR | hsa-miR-376c-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-46186 |
MNDR | hsa-miR-376c-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-46187 |
MNDR | hsa-miR-376c-3p | Her2-receptor positive breast cancer | MNDR-E-MI-46188 |
MNDR | hsa-miR-376c-3p | Breast cancer luminal | MNDR-E-MI-46189 |
MNDR | hsa-miR-376c-3p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-46190 |
MNDR | hsa-miR-376c-3p | Dermatomyositis | MNDR-E-MI-46191 |
MNDR | hsa-miR-376c-3p | Prostate cancer | MNDR-E-MI-46192 |
MNDR | hsa-miR-376c-3p | Gastric cancer | MNDR-E-MI-46193 |
MNDR | hsa-miR-376c-3p | Gastric lymphoma | MNDR-E-MI-46194 |
MNDR | hsa-miR-376c-3p | Alzheimer disease | MNDR-E-MI-46195 |
MNDR | hsa-miR-376c-3p | Bladder cancer | MNDR-E-MI-46196 |
MNDR | hsa-miR-376c-3p | Dysautonomia familial | MNDR-E-MI-46197 |
MNDR | hsa-miR-376c-3p | Distal muscular dystrophy | MNDR-E-MI-46198 |
MNDR | hsa-miR-376c-3p | Duchenne muscular dystrophy | MNDR-E-MI-46199 |
MNDR | hsa-miR-376c-3p | Facioscapulohumeral muscular dystrophy | MNDR-E-MI-46200 |
MNDR | hsa-miR-376c-3p | Head and neck cancer | MNDR-E-MI-46201 |
MNDR | hsa-miR-376c-3p | Cardiovascular disease | MNDR-E-MI-46202 |
MNDR | hsa-miR-376c-3p | Parkinson disease | MNDR-E-MI-46203 |
MNDR | hsa-miR-376c-3p | Basal-like breast cancer | MNDR-E-MI-46204 |
MNDR | hsa-miR-376c-3p | Thyroid cancer | MNDR-E-MI-46205 |
MNDR | hsa-miR-376c-3p | Pituitary neoplasms | MNDR-E-MI-46206 |
MNDR | hsa-miR-376c-3p | Pancreatic cancer | MNDR-E-MI-46207 |
MNDR | hsa-miR-376c-3p | Melanoma | MNDR-E-MI-46208 |
MNDR | hsa-miR-376c-3p | Colon cancer | MNDR-E-MI-46209 |
MNDR | hsa-miR-376c-3p | Colon adenocarcinoma | MNDR-E-MI-46210 |
MNDR | hsa-miR-376c-3p | Ovarian cancer | MNDR-E-MI-46211 |
MNDR | hsa-miR-376c-3p | Prostate adenocarcinoma | MNDR-E-MI-46212 |
MNDR | hsa-miR-376c-3p | Carcinoma ductal breast | MNDR-E-MI-46213 |
MNDR | hsa-miR-376c-3p | Glioblastoma | MNDR-E-MI-46214 |
MNDR | hsa-miR-376c-3p | Glioma | MNDR-E-MI-46215 |
MNDR | hsa-miR-376c-3p | Nemaline myopathy | MNDR-E-MI-46216 |
MNDR | hsa-miR-376c-3p | Epilepsy temporal lobe | MNDR-E-MI-46217 |
MNDR | hsa-miR-376c-3p | Osteosarcoma | MNDR-E-MI-46218 |
MNDR | hsa-miR-376c-3p | Breast carcinoma | MNDR-E-MI-46219 |
MNDR | hsa-miR-376c-3p | Meningioma | MNDR-E-MI-46220 |
MNDR | hsa-miR-376c-3p | Gastric adenocarcinoma | MNDR-E-MI-46221 |
MNDR | hsa-miR-376c-3p | Cervical squamous cell carcinoma | MNDR-E-MI-46222 |
MNDR | hsa-miR-376c-3p | Bone-invasive pituitary adenoma | MNDR-E-MI-46223 |
MNDR | hsa-miR-376c-3p | Lung adenocarcinoma | MNDR-E-MI-46224 |
MNDR | hsa-miR-376c-3p | Adrenocortical cancer | MNDR-E-MI-46225 |
MNDR | hsa-miR-376c-3p | Thyroid carcinoma | MNDR-E-MI-46226 |
MNDR | hsa-miR-376c-3p | Ovarian carcinoma | MNDR-E-MI-46227 |
MNDR | hsa-miR-376c-3p | Bladder urothelial carcinoma | MNDR-E-MI-46228 |
MNDR | hsa-miR-376c-3p | Pancreatic adenocarcinoma | MNDR-E-MI-46229 |
MNDR | hsa-miR-376c-3p | Carcinoma renal cell | MNDR-E-MI-46230 |
MNDR | hsa-miR-376c-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-46231 |
MNDR | hsa-miR-376c-3p | Renal clear cell carcinoma | MNDR-E-MI-46232 |
MNDR | hsa-miR-376c-3p | Cholangiocarcinoma | MNDR-E-MI-46233 |
MNDR | hsa-miR-376c-3p | Esophageal cancer | MNDR-E-MI-46234 |
MNDR | hsa-miR-376c-3p | Lung small cell carcinoma | MNDR-E-MI-46235 |
MNDR | hsa-miR-376c-3p | Synovial sarcoma | MNDR-E-MI-46236 |
MNDR | hsa-miR-376c-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-46237 |
MNDR | hsa-miR-376c-3p | Breast invasive carcinoma | MNDR-E-MI-46238 |
MNDR | hsa-miR-376c-3p | Hepatocellular carcinoma | MNDR-E-MI-46239 |
MNDR | hsa-miR-376c-3p | B-cell lymphoma | MNDR-E-MI-46240 |
MNDR | hsa-miR-376c-3p | Rheumatoid arthritis | MNDR-E-MI-46241 |
MNDR | hsa-miR-376c-3p | T-cell leukemia | MNDR-E-MI-46242 |
MNDR | hsa-miR-376c-3p | Barrett's adenocarcinoma | MNDR-E-MI-46243 |
MNDR | hsa-miR-376c-3p | Hodgkin lymphoma | MNDR-E-MI-46244 |
MNDR | hsa-miR-376c-3p | Burkitt lymphoma | MNDR-E-MI-46245 |
MNDR | hsa-miR-376c-3p | Crohn disease | MNDR-E-MI-46246 |
MNDR | hsa-miR-376c-3p | Tonsil cancer | MNDR-E-MI-46247 |
MNDR | hsa-miR-376c-3p | Colorectal cancer | MNDR-E-MI-46248 |
MNDR | hsa-miR-376c-3p | Multiple myeloma | MNDR-E-MI-46249 |
MNDR | hsa-miR-376c-3p | Ovarian epithelial cancer | MNDR-E-MI-46250 |
MNDR | hsa-miR-376c-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-46251 |
MNDR | hsa-miR-376c-3p | Stroke lacunar | MNDR-E-MI-46252 |
MNDR | hsa-miR-376c-3p | Barrett's carcinogenesis | MNDR-E-MI-46253 |
MNDR | hsa-miR-376c-3p | Breast cancer her3+ negative | MNDR-E-MI-46254 |
MNDR | hsa-miR-376c-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-46255 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ACVR1C | Homo sapiens | RR00039085 |
TOP